ProTA Therapeutics' Unattributed VC Round

ProTA Therapeutics raised a round of funding on May 29, 2017. Investors include OneVentures.

ProTA Therapeutics (Probiotic Therapies for Allergy) is an immunotherapy technology developer aiming to commercialize new peanut allergy treatments for children. The allergy treatment that combines a …

Articles about ProTA Therapeutics' Unattributed VC Round: